Athenahealth, Inc.
ATHN
ATHN was delisted on the 11th of February, 2019.
275 hedge funds and large institutions have $6.63B invested in Athenahealth, Inc. in 2018 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 85 increasing their positions, 83 reducing their positions, and 47 closing their positions.
74% more call options, than puts
Call options by funds: $299M | Put options by funds: $172M
36% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 47
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
6% more funds holding
Funds holding: 259 → 275 (+16)
5% more capital invested
Capital invested by funds: $6.29B → $6.63B (+$343M)
2% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 83
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$46.4M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$36.7M |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$35.2M |
| 4 |
EM
Elliott Management
New York
|
+$30.4M |
| 5 |
PA
Perceptive Advisors
New York
|
+$22.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$205M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$124M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$57.9M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$44.8M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$43.2M |
ATHN Hedge Fund Activity: Q2 2018 in Review
275 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Athenahealth, Inc. (ATHN) for Q2 2018, worth a combined $6.63B — up 5.5% from $6.29B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new ATHN positions and 47 closed out — a net gain of 17 holders — while 85 added to existing stakes and 83 trimmed.
The largest buyer was Credit Suisse, adding an estimated $46.4M. The largest seller was Fidelity Investments, cutting an estimated $205M.
- 275 institutional investors held Athenahealth, Inc. (ATHN) as of Q2 2018, up from 259 in Q1 2018.
- Funds reported $6.63B of Athenahealth, Inc. stock for Q2 2018, up 5.5% quarter-over-quarter.
- 64 funds opened new Athenahealth, Inc. positions in Q2 2018 and 47 closed out, a net change of +17 holders.
- The largest Athenahealth, Inc. buyer in Q2 2018 was Credit Suisse, an estimated $46.4M added.
- The largest Athenahealth, Inc. seller in Q2 2018 was Fidelity Investments, an estimated $205M sold.
Based on aggregated 13F filings for Q2 2018.